Mednet Logo
HomeRheumatologyQuestion

How would the presence of active rheumatoid arthritis on methotrexate impact your choice of fractionation for a patient with prostate cancer?

1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It depends on the dose of MTX.

For 7.5-10 mg weekly doses have not changed volume or dose but if on a higher dose of MTX then I would discuss with rhematologist for possible holding or decreasing dose of MTX (as in that range has known radiosensitizing effect)

Register or Sign In to see full answer

How would the presence of active rheumatoid arthritis on methotrexate impact your choice of fractionation for a patient with prostate cancer? | Mednet